Celldex (CLDX)
36.26
-0.76 (2.05%)
Upcoming Events
Latest Headlines
Form ARS Celldex Therapeutics, For: Dec 31
April 25, 2024 4:06 PM - SEC Filing
Form DEF 14A Celldex Therapeutics, For: Jun 13
April 25, 2024 8:01 AM - SEC Filing
Celldex (CLDX) Announces Completion of Enrollment in Phase 2 Study of Barzolvolimab in Patients with Chronic Inducible Urticaria
April 17, 2024 8:05 AM - StreetInsider
Celldex Announces Completion of Enrollment in Phase 2 Study of Barzolvolimab in Patients with Chronic Inducible Urticaria
April 17, 2024 8:01 AM - Globe NewsWire
Celldex Therapeutics to Participate in the Leerink Partners Global Biopharma Conference
March 8, 2024 7:00 AM - Globe NewsWire
Celldex Therapeutics to Present at TD Cowen’s 44th Annual Health Care Conference
March 5, 2024 10:30 AM - Globe NewsWire
Celldex Therapeutics Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares
March 5, 2024 10:10 AM - Globe NewsWire
Form 8-K Celldex Therapeutics, For: Feb 28
March 1, 2024 4:10 PM - SEC Filing
Form 424B5 Celldex Therapeutics,
March 1, 2024 4:09 PM - SEC Filing
Celldex (CLDX) Announces Pricing of $400 mln Public Offering of Common Stock
February 29, 2024 9:15 PM - StreetInsider
Celldex Therapeutics Announces Pricing of Upsized $400 Million Public Offering of Common Stock
February 29, 2024 9:14 PM - Globe NewsWire
Form 424B5 Celldex Therapeutics,
February 28, 2024 4:13 PM - SEC Filing
Celldex (CLDX) Announces Proposed $250M Share Offering
February 28, 2024 4:01 PM - StreetInsider
Celldex Therapeutics Announces Proposed Public Offering of Common Stock
February 28, 2024 4:01 PM - Globe NewsWire
Celldex Therapeutics (CLDX) PT Raised to $35 at Wells Fargo
February 28, 2024 6:04 AM - StreetInsider
Celldex Therapeutics (CLDX) PT Raised to $90 at Guggenheim
February 26, 2024 12:51 PM - StreetInsider
Form 424B5 Celldex Therapeutics,
February 26, 2024 8:19 AM - SEC Filing
Celldex (CLDX) Misses Q4 EPS by 7c
February 26, 2024 7:15 AM - StreetInsider
Form 10-K Celldex Therapeutics, For: Dec 31
February 26, 2024 7:06 AM - SEC Filing
Form 8-K Celldex Therapeutics, For: Feb 26
February 26, 2024 7:02 AM - SEC Filing
Celldex Reports Fourth Quarter and Year End 2023 Financial Results and Provides Corporate Update
February 26, 2024 7:01 AM - Globe NewsWire
Celldex (CLDX) Presents Positive 12 Week Results from Barzolvolimab Phase 2 Study
February 25, 2024 8:40 PM - StreetInsider
Celldex Therapeutics Presents Positive 12 Week Results from Barzolvolimab Phase 2 Study in Chronic Spontaneous Urticaria
February 24, 2024 2:05 PM - Globe NewsWire
Celldex (CLDX) March calls active
February 20, 2024 2:36 AM - StreetInsider
Celldex (CLDX) March call spreader active
February 16, 2024 3:35 PM - StreetInsider
Form 4 Celldex Therapeutics, For: Feb 13 Filed by: Jimenez Freddy A.
February 15, 2024 4:07 PM - SEC Filing
Form SC 13G/A Celldex Therapeutics, Filed by: Point72 Asset Management, L.P.
February 14, 2024 4:18 PM - SEC Filing
Form SC 13G Celldex Therapeutics, Filed by: Kynam Capital Management, LP
February 14, 2024 12:53 PM - SEC Filing
Form SC 13G Celldex Therapeutics, Filed by: EVENTIDE ASSET MANAGEMENT, LLC
February 14, 2024 11:49 AM - SEC Filing
Form SC 13G/A Celldex Therapeutics, Filed by: RTW INVESTMENTS, LP
February 14, 2024 7:38 AM - SEC Filing
Form SC 13G/A Celldex Therapeutics, Filed by: VANGUARD GROUP INC
February 13, 2024 5:03 PM - SEC Filing
Form SC 13G Celldex Therapeutics, Filed by: Polar Capital Holdings Plc
February 13, 2024 9:41 AM - SEC Filing
Form SC 13G/A Celldex Therapeutics, Filed by: FMR LLC
February 9, 2024 8:51 AM - SEC Filing
Form SC 13G/A Celldex Therapeutics, Filed by: WELLINGTON MANAGEMENT GROUP LLP
February 8, 2024 10:12 AM - SEC Filing
Celldex to Participate in the Guggenheim Healthcare Talks 6th Annual Biotechnology Conference
February 6, 2024 4:01 PM - Globe NewsWire
Celldex Announces Upcoming Presentation of Barzolvolimab Phase 2 Results in Chronic Spontaneous Urticaria at AAAAI 2024
February 5, 2024 8:01 AM - Globe NewsWire
Form SC 13G/A Celldex Therapeutics, Filed by: BlackRock Inc.
January 26, 2024 5:26 PM - SEC Filing
Full Article List
